1.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: MM-ADJ-5, NCT00226408
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E1609, E1609, NCT01274338
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Approved-not yet active Age: 18 to 65 Sponsor: Other Protocol IDs: 2011-0073, NCT01409174
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Approved-not yet active Age: 18 to 65 Sponsor: Other Protocol IDs: 2011-0847, NCT01603212
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 16 to 75 Sponsor: Other Protocol IDs: CDR0000543536, SINGAPORE-OC-GI-01-06, SINGAPORE-IRB-06-16-HEP, SINGAPORE-CTC0600327, SPRI-SINGAPORE-OC-GI-01-06, OC-GI-01-06, NCT00471484
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: LUD2007-001, UPCI07-023, UCH15689B, NCT00679289
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: D0708, NIH grant R01CA095648, NCT00913913
|
|
8.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: not specified Sponsor: Other Protocol IDs: CASE2609, NCI-2010-00640, NCT01100528
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DARENCA-1, NCT01274273
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 12-09, NCT01658813
|
|
11.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: OSU-2005H0005, 0312, 5633, NCI-5633, NCT00217373
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 09-021, 1P50CA121973-01A1, NCT01622933
|
|
13.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-067, NCT00871533
|
|
14.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 11-063, NCT01608594
|